XXI Wealth’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.09M Buy
12,948
+2,329
+22% +$388K 0.84% 25
2026
Q2
$2.01M Sell
10,619
-628
-6% -$118K 0.93% 27
2026
Q1
$2.22M Sell
11,247
-686
-6% -$132K 1.26% 19
2025
Q4
$2.19M Buy
+11,933
New +$2.09M 1.33% 17

Other funds holding AZN

XXI Wealth's AZN Position: Q3 2026 in Review

XXI Wealth increased its AstraZeneca (AZN) stake by 22% in Q3 2026, buying an estimated $388K and bringing the position to 12,948 shares worth $2.09M. The position accounts for 0.84% of the portfolio, ranked #25.

XXI Wealth first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.22M in Q1 2026. 1,242 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • XXI Wealth held 12,948 shares of AstraZeneca worth $2.09M as of Q3 2026.
  • XXI Wealth bought 2,329 AstraZeneca shares in Q3 2026, an estimated $388K.
  • AstraZeneca made up 0.84% of XXI Wealth's portfolio in Q3 2026, its #25 holding.
  • XXI Wealth first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • XXI Wealth's AstraZeneca position peaked at $2.22M in Q1 2026.
  • 1,242 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.